An AML Targeted Duplex Sequencing Assay That Can Detect Measurable Residual Disease (MRD) at a Sensitivity Better Than 0.01% Variant Allele Frequency

Autor: McElwain, Mark, Olson, Janice M, Zannette, Camila, Nguyen, Karen, Fitzgerald, Devon M, Lee, Isabel Y, Schmidt, Elizabeth, Vavra, Kevin C, Gillis, Laura B, Gordon, Kelly J, Wakeman, Wayne B, Smith, Thomas H, Salk, Jesse J, Higgins, Jake, Harrell, Jill C, Chu, Frances, Meredith, Gavin D
Zdroj: In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S101-S102
Databáze: ScienceDirect